BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study.

Autor: Ecke TH; Department of Urology, Helios Hospital, Bad Saarow, Germany; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. Electronic address: thorsten.ecke@helios-gesundheit.de., Meisl CJ; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Schlomm T Prof; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Rabien A; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Labonté F; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Rong D; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Hofbauer S; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Friedersdorff F Prof; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Department of Urology, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany., Sommerfeldt L; Department of Urology, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany., Gagel N; Department of Urology, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany., Gössl A; Department of Urology, Rheinland Klinikum Neuss, Neuss, Germany., Barski D; Department of Urology, Rheinland Klinikum Neuss, Neuss, Germany., Otto T Prof; Department of Urology, Rheinland Klinikum Neuss, Neuss, Germany; University Hospital Essen, Essen, Germany., Grunewald CM; Department of Urology, University Hospital, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Niegisch G Prof; Department of Urology, University Hospital, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Hennig MJP; Department of Urology, University Hospital Lübeck, Lübeck, Germany., Kramer MW Prof; Department of Urology, University Hospital Lübeck, Lübeck, Germany., Koch S Prof; Helios Hospital, Institute of Pathology, Bad Saarow, Germany; Brandenburg Medical School, Brandenburg, Germany., Roggisch J; Helios Hospital, Institute of Pathology, Bad Saarow, Germany., Hallmann S; Department of Urology, Helios Hospital, Bad Saarow, Germany., Weiß S; Department of Urology, Helios Hospital, Bad Saarow, Germany., Waldner M; Department of Urology, St. Elisabeth Hospital, Cologne, Germany., Graff J; Department of Urology, St. Elisabeth Hospital, Cologne, Germany., Veltrup E; STRATIFYER Molecular Pathology GmbH, Cologne, Germany., Linden F; STRATIFYER Molecular Pathology GmbH, Cologne, Germany., Hake R; Institute of Pathology, St. Elisabeth Hospital, Cologne, Germany., Eidt S; Institute of Pathology, St. Elisabeth Hospital, Cologne, Germany., Wirtz RM; STRATIFYER Molecular Pathology GmbH, Cologne, Germany.

Publikováno v: Urologic oncology [Urol Oncol] 2023 Dec; Vol. 41 (12), pp. 484.e17-484.e26. Date of Electronic Publication: 2023 Jul 04.

BTA stat®, Alere NMP22® BladderChek®, UBC® rapid test/visual, uromonitor® und Zytologie beim Harnblasenkarzinom: Update der deutschen Multicenter-Studie

Autor: Ecke, T., Friedersdorff, F., Schlomm, T., Meisl, C., Hofbauer, S., Labonté, F., Rabien, A., Gössl, A., Barski, D., Otto, T., Grunewald, C., Niegisch, G., Hennig, M., Kramer, M., Hallmann, S.

Publikováno v: 61. Jahrestagung der Südwestdeutschen Gesellschaft für Urologie e.V.; 20210609-20210611; sine loco [digital]; DOC21swdgu79 /20210608/

Einleitung: BTA stat®, Alere NMP22® BladderChek®, UBC® rapid test und UBC® rapid visual sind urinbasierte Schnelltests zur Detektion von Harnblasenkarzinomen; uromonitor® ist ein urinbasierter Test zur Bestimmung der Mutationen FGFR3, TERT und

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b9eeb101624d0ba8607b2927ac117fc
http://www.egms.de/en/meetings/swdgu2021/21swdgu79.shtml

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Symmetry Detection in Autistic Adults Benefits from Local Processing in a Contour Integration Task.

Autor: Subri, Sabrina¹ sabrinasubri@uitm.edu.my, Palumbo, Letizia², Gowen, Emma³

Publikováno v: Journal of Autism & Developmental Disorders. Oct2024, Vol. 54 Issue 10, p3684-3696. 13p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.